News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Mediomics, LLC Awarded Phase I Contract from National Institutes of Health (NIH): Will Receive $185,000 for Development of Molecular Pincer-based In-Process Analyzer for Biologics


10/13/2010 10:16:48 AM

ST. LOUIS--(BUSINESS WIRE)--Mediomics, LLC has been awarded an $185,000 Phase I SBIR contract (HHSN261201000040C) from the National Cancer Institute. The major goal of this project is to develop a hand-held biosensor and PINCERâ„¢-based assay reagents for in-process analysis of biologics production. This project will culminate with beta testing by a collaborating third-party manufacturer. Since 2007, Mediomics has received more than two million dollars of US government funding to develop its quick and sensitive homogenous PINCERâ„¢ protein assay.

Read at BioSpace.com

Related News

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES